SEC Form 4 · accession 0001179110-17-008387
ENDOCYTE INC · ECYT
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Michael A. Sherman
Officer — President, CEO and CFO · Director
Period of report
May 31, 2017
Accepted (ET)
Jun 2, 2017 · 8:14 am EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001235007
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | May 31, 2017 | M | 44,285 | $2.10 | A | 208,111 | D | |
| Common Stock | holding | — | — | — | 19,919 | I | By Sherman Investors, LLC |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (right to buy)F1 | $2.10 | May 31, 2017 | M | 44,285 | D | — | May 31, 2017 | Common Stock | 44,285 | 0 | D |
Explanation of responses
- F1This option is fully vested and immediately exercisable.